Functional features of EVI1 and EVI1Δ324 isoforms of MECOM gene in genome-wide transcription regulation and oncogenicity

被引:0
|
作者
A Sayadi
J Jeyakani
S H Seet
C-L Wei
G Bourque
F A Bard
N A Jenkins
N G Copeland
E A Bard-Chapeau
机构
[1] Institute of Molecular and Cell Biology,
[2] Genome Institute of Singapore,undefined
[3] 3Current address: The Methodist Hospital Research Institute,undefined
[4] Houston,undefined
[5] TX,undefined
[6] USA.,undefined
[7] 4Current address: Novartis Institutes for Biomedical Researtch,undefined
[8] WKL-125.1.05A,undefined
[9] Basel CH-4002,undefined
[10] Switzerland.,undefined
来源
Oncogene | 2016年 / 35卷
关键词
D O I
暂无
中图分类号
学科分类号
摘要
The MDS1 and ecotropic viral integration site 1 (EVI1) complex locus (MECOM) gene encodes several transcription factor variants including MDS1-EVI1, EVI1 and EVI1Δ324. Although MDS1-EVI1 has been associated with tumor-suppressing activity, EVI1 is a known oncogene in various cancers, whose expression is associated with poor patient survival. Although EVI1Δ324 is co-transcribed with EVI1, its activity in cancer cells is not fully understood. Previous reports described that unlike EVI1, EVI1Δ324 protein cannot transform fibroblasts because of its disrupted N-terminal zinc finger (ZNF) domain. To better understand EVI1Δ324 biology and function, we obtained genome-wide binding occupancies and expression data in ovarian cancer cells. We characterized its DNA-binding sites, binding motif and target genes. Comparative analyses with previous study show that EVI1 and EVI1Δ324 share similar transcriptional activities linked to their common C-terminus ZNF domain. They bind to an E-twenty-six family (ETS)-like motif, target to a large extent the same genes and cooperate with AP1 transcription factor. EVI1Δ324-occupied genes were 70.7% similar to EVI1-bound genes. More strikingly, EVI1 and EVI1Δ324 differentially expressed genes were 99.87% identical, indicating comparable transcriptional regulatory functions. Consistently with gene ontologies linked to these target genes, EVI1Δ324 expression in HeLa cells could enhance anchorage-independent growth, such as EVI1, showing that EVI1Δ324 expression also lead to pro-oncogenic effects. The main specific feature of EVI1 variant is its N-terminus ZNF domain that binds DNA through GATA-like motif. We found that most GATA-like EVI1 chromatin immunoprecipitation sequencing peaks are far from genes and are not involved in transcriptional regulation. These genomic regions were enriched in simple sequence repeats and displayed high meiotic recombination rates. Overall, our genomics analyses uncovered common and specific features of two major MECOM isoforms. Their influence on transcription and downstream cell proliferation was comparable. However, EVI1-specific GATA-like binding sites, from its N-terminus ZNF domain, associated with high recombination rates, suggesting possible additional oncogenic potential for EVI1 in modulating genomic stability.
引用
收藏
页码:2311 / 2321
页数:10
相关论文
共 50 条
  • [1] Functional features of EVI1 and EVI1Δ324 isoforms of MECOM gene in genome-wide transcription regulation and oncogenicity
    Sayadi, A.
    Jeyakani, J.
    Seet, S. H.
    Wei, C-L
    Bourque, G.
    Bard, F. A.
    Jenkins, N. A.
    Copeland, N. G.
    Bard-Chapeau, E. A.
    [J]. ONCOGENE, 2016, 35 (18) : 2311 - 2321
  • [2] The EVI1 gene in myeloid leukemia
    Nucifora, G
    [J]. LEUKEMIA, 1997, 11 (12) : 2022 - 2031
  • [3] The EVI1 gene in myeloid leukemia
    G Nucifora
    [J]. Leukemia, 1997, 11 : 2022 - 2031
  • [4] GENOME-WIDE IDENTIFICATION OF BINDING SITES OF EVI1 IN HUMAN MYELOID CELL LINES
    Maicas, M.
    Vazquez, I.
    Garcia-Sanchez, M. A.
    Marcotegui, N.
    Garcia-Orti, L.
    Marin, O.
    Ortega, N.
    Guruceaga, E.
    Conchillo, A.
    Gomez-Benito, M.
    Odero, M. D.
    [J]. HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2009, 94 : 7 - 7
  • [5] Predictors of Outcomes in Patients With MECOM EVI1 Rearranged AML or MDS
    Kusne, Yael
    McGary, Alyssa
    Kelemen, Katalin
    Litzow, Mark
    Al-Kali, Aref
    Foran, James
    Badar, Talha
    Patnaik, Mrinal
    Mangaonkar, Abhishek
    Sproat, Lisa
    Palmer, Jeanne
    Greipp, Patricia
    Yi, Cecilia Arana
    [J]. CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2023, 23 : S318 - S318
  • [6] Novel Bone Marrow Failure Syndrome Due to a Deletion of the EVI1/Mecom Gene
    van der Veken, Lars T.
    Bierings, Marc
    Maiburg, Merel
    Groenendaal, Floris
    Bloem, Andries C.
    Knoers, Nine V.
    Buijs, Arjan
    [J]. BLOOD, 2012, 120 (21)
  • [7] Evaluation of EVI1 and EVI1s (Δ324) as potential therapeutic targets in ovarian cancer
    Jazaeri, Amir A.
    Ferriss, J. Stuart
    Bryant, Jennifer L.
    Dalton, M. Susan
    Dutta, Anindya
    [J]. GYNECOLOGIC ONCOLOGY, 2010, 118 (02) : 189 - 195
  • [8] EXPRESSION OF EVI1 IN ACUTE PROMYELOCYTIC LEUKEMIA (APL) AND REGULATION OF EVI1 BY ALL-TRANS-RETINOIC ACID (ATRA)
    RUSSELL, M
    WOODWARD, S
    TAETLE, R
    [J]. BLOOD, 1993, 82 (10) : A250 - A250
  • [9] Gene therapy activates EVI1, destabilizes chromosomes
    Cynthia E Dunbar
    Andre Larochelle
    [J]. Nature Medicine, 2010, 16 : 163 - 165
  • [10] EVI1 up-regulates the stress responsive gene SIRT1 which triggers deacetylation and degradation of EVI1
    Pradhan, Anjan Kumar
    Kuila, Nivedita
    Singh, Sneha
    Chakraborty, Soumen
    [J]. BIOCHIMICA ET BIOPHYSICA ACTA-GENE REGULATORY MECHANISMS, 2011, 1809 (4-6): : 269 - 275